A Mohammad1, A Kilcoyne, U Bond, M Regan, M Phelan. 1. Department of Rheumatology, South Infirmary Victoria University Hospital, Cork, Ireland. ausafmohammad@gmail.com
Abstract
INTRODUCTION: I n order to assess the value of using the methotrexate information booklet, we conducted a single blind prospective controlled trial of the patients attending two rheumatology services. METHODS: The active-arm (n=40) used the MTX information booklet for the patients' education and the control-arm (n=38) did not. Patients' interviews were conducted over a 6-month period using an MTX-questionnaire. RESULTS: The entire active-arm patients (100%) were taking folic-acid and 32 (80%) knew the reason why they were taking folic-acid vs. [30 (79%) and 10 (26%) in the control-arm]. In the active-arm 35 (88%) knew the reason for their monthly blood tests vs. 18 (47%) in the control-arm. The entire active-arm was aware of the need for contraception use and MTX-side effects vs. 23 (60%) and 15 (40%) in the control-arm respectively. CONCLUSIONS: The use of the MTX information booklet in our cohort improved their understanding of the treatment.
RCT Entities:
INTRODUCTION: I n order to assess the value of using the methotrexate information booklet, we conducted a single blind prospective controlled trial of the patients attending two rheumatology services. METHODS: The active-arm (n=40) used the MTX information booklet for the patients' education and the control-arm (n=38) did not. Patients' interviews were conducted over a 6-month period using an MTX-questionnaire. RESULTS: The entire active-arm patients (100%) were taking folic-acid and 32 (80%) knew the reason why they were taking folic-acid vs. [30 (79%) and 10 (26%) in the control-arm]. In the active-arm 35 (88%) knew the reason for their monthly blood tests vs. 18 (47%) in the control-arm. The entire active-arm was aware of the need for contraception use and MTX-side effects vs. 23 (60%) and 15 (40%) in the control-arm respectively. CONCLUSIONS: The use of the MTX information booklet in our cohort improved their understanding of the treatment.
Authors: J Patermann; I Ehlebracht-König; G Lind-Albrecht; E Genth; A Reusch; R Küffner; U Müller-Ladner; J Braun Journal: Z Rheumatol Date: 2016-03 Impact factor: 1.372
Authors: Francoise Fayet; Bruno Pereira; Angelique Fan; Malory Rodere; Carine Savel; Pauline Berland; Martin Soubrier; Anne Tournadre; Jean Jacques Dubost Journal: Rheumatol Int Date: 2021-05-29 Impact factor: 2.631
Authors: Rhiannon Phillips; Bethan Pell; Aimee Grant; Daniel Bowen; Julia Sanders; Ann Taylor; Adrian Edwards; Ernest Choy; Denitza Williams Journal: BMC Rheumatol Date: 2018-07-27